Article
High expression of CD52 mRNA predicts poor prognosis for cytogenetic normal acute myeloid Leukemia patients
2020-03-27
Abstract excerpt
<title>Abstract</title> <p>Background: The prognosis of cytogenetic normal acute myeloid leukemia (CN-AML) varies. Finding new biomarkers affecting the prognosis of these patients may bring a new strategy for precise classification and treatment. CD52 plays a significant role in chronic lymphocytic leukemia (CLL). However, the potential role of CD52 in CN-AML remains largely elusive. <h4>Methods:</h4> We analyzed...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c715c856-bf47-54a1-8ea0-1e84fde41df2
- DOI
- 10.21203/rs.2.22823/v2
